Hers Review
✓ Updated July 2026
By the TelehealthIndex Editorial Team · How we score Not Recommended · #8 in Women's Health
By the TelehealthIndex Editorial Team · Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a
provider through links on this page, we may earn a commission at no extra cost to you.
Commissions never influence our scores or rankings — several of our top-rated providers pay
us nothing. How we score → · Full disclosure →
Caution: unresolved FDA warning letter. This provider stays at its computed rank; its score is capped under
our methodology and it is not recommended while the matter is open.
46.5/100
Hers score
Not Recommended · #8 in Women's Health · Data as of July 2026
Clinical credibilityWeak
Regulatory & safety recordSerious deductions
Transparency & trustGood
Access & coverageMixed
Customer experienceGood
Value & pricingGood
Pillar ratings are qualitative summaries of our internal rubric; we do not publish the
point weights. Read the full methodology →
TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.
What it is
Women's arm of Hims & Hers: weight loss, hair, mental health meds, skincare, menopause; cash-pay subscriptions.
Strengths
- Available nationwide (50 states)
- Lower-cost pricing for the category
Considerations
- Same FDA warning letter (Sept 2025, dba Hers) and parent-level litigation as Hims - Caution gate applies
- Reported 2026 data-breach incident; FTC investigation reported 2025
Founded2018
OwnershipPublic (Hims & Hers, NYSE: HIMS)
AvailabilityNationwide (50 states)
InsuranceNo
Money-back guaranteeNot advertised
PricingWeight $39 first month then ~$149/mo; hair from $29/mo; most verticals $20-85/mo
Visit Hers
We may earn a commission — disclosure.
Alternatives to consider
Sources
Every regulatory claim on this page is cited to its primary source (or the issuing agency's database). Verified against the cited document; see our Editorial Policy.
Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →